Folic acid prophylaxis: Not only against neural tube defects;Folsaureprophylaxe: Nicht nur zur verhutung von neuralrohrdefekten

Monatsschrift fur Kinderheilkunde

Volumn 147, Issue 4, 1999, Pages 320-326

  Tonz O ^a   Luzern, ^b  

^a NONE   (Switzerland)

^b NONE

Author keywords

Folic acid; General Prevention; Homocysteine Metabolism; Malformations; Neural tube defects

Indexed keywords

FOLIC ACID;

FOOD COMPOSITION; HUMAN; MATERNAL NUTRITION; NEURAL TUBE DEFECT; PRIMARY PREVENTION; REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0032924810     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050429     Document Type: Review

References (38)

1. Alpert JE, Fava M (1997) Nutrition and depression. Nutr Rev 55:145-149
2. Bailey LB (1998) Dietary reference intakes for folate: the debut of dietary folate equivalents. Nutr Rev 56:294-299
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessement of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
4. Bower C (1996) Folate and the prevention of birth defects. Austr J Nutr Diet [Suppl] 53:55-8
5. Brönstrup A, Hages M, Prinz-Langenohl R, Pietrzik K (1998) Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr 68:1104-1110
6. Bunin GR,Kuijten RR, Buckley JD et al. (1993) Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in children. N Engl J Med 329:536-541
7. Butterworth CE, Bendich A (1996) Folic acid and the prevention of birth defects. Ann Rev Nutr 18:73-97
8. Butterworth CH, Hatch KD,Macaluso M et al. (1992) Folate deficiency and cervical dysplasias. JAMA 267:528-533
9. Center for Disease Control and Prevention (1993) Position paper on folic acid food fortification and the prevention of spina bifida and anencephaly. Center for Disease Control and Prevention, Atlanta
10. Czeisel AE (1995) Folic acid in the prevention of neural tube defects. J Pediatr Gastroenterol Nutr 20:4-16
11. Czeisel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835
12. Czeisel AE, Merhala Z (1998) Bread fortification with folic acid, vitamin B12, and vitamin B6 in Hungary (Letter). Lancet 352:1225
13. Czeisel AE, Dudás I, Fritz G et al. (1992) The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet 251:181-185
14. Daly S, Mills JL, Molloy AM et al.(1997) Minimum effective dose of folic acid for fortification to prevent neural-tube defects. Lancet 350:1666-1669
15. Deutsche Gesellschaft für Ernährung (1996) Ernährungsbericht 1996. Deutsche Gesellschaft für Ernährung e.V., Frankfurtam Main, S 48
16. Eskes TKAB ( 1998) Open or closed? A world of difference: a history of homocystein research. Eur J Obstet Gynecol Reprod Med 78:169-177
17. Giovannucci E, Stampfer MJ, Colditz GA et al. (1993) Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85:875-884
18. Golden GS (1987) Textbook of pediatric neurology. Plenum Medical Book Compagny, New York London, p 4
19. Jacques PF, Bostom AG, Williams RR et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentration. Circulation 93:7-9
20. Kirke PN, Daly LE, Elwood JH (1991) A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Childh 67:1442-1446
21. Kirke PN, Molloy AM, Daly LE et al. (1993) Maternal plasma folate and vitamin B12 a re independent risk factors for neural tube defects. QJM 86:703-708
22. Li D-K, Daling JR, Müller BA et al. (1995) Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:212-218
23. Lucock MD, Wild J, Lumb CH et al. (1997) Risk of neural tube defect-affected pregnancy is associated with a block of maternal one-carbon metabolism at the level of N-5-methyl-tetrahydrofolate: homocysteine methyltransferase. Biochem Mol Med 61:20-48
24. McCully KS (1997) The Homocysteine revoution: medicine for the new millenium. Keats Publishing, New Canaan
25. Mills JL, McPartlin JM, Kirke PN et al. (1995) Homocystein metabolism in pregnancies complicated by neural tube defects. Lancet 345:149-151
26. MRC vitamin study research group (1991) Prevention of neural tube defects. Results of the Medical Research Council Vitamin Study. Lancet 338:131-137
27. Müller H (1995) Die Folsäure-Aufnahme mit der täglichen Gesamtnahrung - Einfluss der Speisenzubereitung auf deren Folsäuregehalt.Z Lebensm Unters Forsch 200:209-212
28. Rimm EB, Willett WC, Hu FB et al. (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359-364
29. Shaw GM, Lammer EJ,Wassermann CR et al. (1995) Risk of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346:393-396
30. Shaw GM,Velie EM, Schaffer DM (1997) Is dietary intake of methionine associated with a reduction in risk for neural tube defect-associated pregnancies? Teratology 56:295-299
31. Smithells RW, Sheppard S, Shorah CJ et al. (1980) Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1:399-340
32. Smithells RW, Nevin NC, Seller MJ et al. (1983) Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031
33. Tönz O, Lüthy J, Raunhardt O (1996) Folsäure zur Verhütung von Neuralrohrdefekten. Schweiz Med Wochenschr 126:177-187
34. Tolarová M (1997) Orofacial clefts in Czechoslovakia. Scand J Plast Reconstr Surg 21:19-25
35. Tucker KL, Mahnken B, Wilson PWF et al. (1996) Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA 376:1879
36. U.S. Departement of Health and Human Services (1992) Recommendations for the use of folk acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Weekly Rep (MMWR) 41:1-7
37. Van der Put NMJ, Van den Heuvel LP, Steegers-Theunissen RPM et al. (1996) Decreased methylentetrahydrofolate reductase due to the 677 C-T mutation in families with spina bifida offspring. J Mol Med 74:691-694
38. Van der Put NMJ, Eskes TKAB, Blom HJ et al. (1997) Is the common 677 C-T mutation in the methylene-tetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 90:111-115